Status:
UNKNOWN
Prevalence and Burden of Nausea and Vomiting in Pregnant Women in Switzerland: Survey Purity 2022
Lead Sponsor:
Effik SA
Collaborating Sponsors:
Opera CRO, a TIGERMED Group Company
Conditions:
Nausea
Vomiting of Pregnancy
Eligibility:
FEMALE
18+ years
Brief Summary
The latest data on the prevalence of nausea in pregnancy in Switzerland is dated 2015 but has been hypothesised that the recent introduction on the market of new drugs against this symptom could modif...
Detailed Description
Nausea with or without vomiting (Nausea and Vomiting in Pregnancy - NVP) in early pregnancy (before 9 and up to 16 weeks of gestation) is very common (50-80%); these symptoms rarely persist throughout...
Eligibility Criteria
Inclusion
- Subjects will be eligible for inclusion if all the following criteria are respected:
- Women aged ≥ 18 years.
- Women in physiological pregnancy and between the 18th and 22nd week of pregnancy (at time of morphological ultrasound).
- Women able to communicate adequately with the Investigator and able to read, understand and provide the answers required by the questionnaires in one of the languages in which they will be provided (Italian, German, French or English).
- Women able to understand and who can provide valid informed consent to the Survey.
Exclusion
- Subjects fulfilling one or more of the following exclusion criteria will not be included in the study:
- Twin pregnancy.
- Medically assisted procreation (MAP).
Key Trial Info
Start Date :
September 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2024
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06055192
Start Date
September 1 2023
End Date
October 1 2024
Last Update
September 26 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.